A future of personalised medicine in breast
expressTec is a biotech start-up company and a spin-off from the University of Algarve, founded by two women scientists. During our successful research careers, we always felt the need to accomplish the last step of taking our scientific discoveries to the patient’s bedside.
In 2021, winning the “Born from Knowledge - Ideas” contest, promoted by the National Agency for Innovation (ANI), motivated us to create expressTEC to support that last step. Ever since we have been developing our entrepreneurial and business skills and aim to dedicate ourselves fully to expressTEC and our shared vision.
Bio-tech Start Up
Founded by two women scientists
power of RNA analysis
Transform the way
eligibility testing is conducted
impacting the lives of breast cancer patients
Contributing to advancements in precision medicine
enabling clinicians to make informed treatment decisions
A better framework to clinicians